يعرض 1 - 10 نتائج من 14 نتيجة بحث عن '"Artemisinins -- pharmacology"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    المساهمون: Harbin Engineering University (HRBEU), Research Center for Molecular Medicine of the Austrian Academy of Sciences [Vienna, Austria] (CeMM ), Austrian Academy of Sciences (OeAW), CeMM Research Center for Molecular Medicine [Vienna, Austria], Novo Nordisk A/S , Danemark, Novo Nordisk, Institut de Biologie Valrose (IBV), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Institute for Research on Cancer and Aging, Nice (IRCAN), INSERM, U1081, CNRS UMR 7284, Nice, Innsbruck Medical University [Austria] (IMU), Leopold Franzens Universität Innsbruck - University of Innsbruck, Medizinische Universität Wien = Medical University of Vienna, Karolinska Institutet [Stockholm], Tumor Immunology [Vienna, Austria] (Children’s Cancer Research Institute), St. Anna Kinderkrebsforschung e.V. [Vienna, Austria], CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria, Physiological Chemistry, Biocenter, Am Hubland, Julius-Maximilians-Universität Würzburg [Wurtzbourg, Allemagne] (JMU), IBM PSSC Montpellier - Innovation Lab., IBM PSSC Montpellier, Physiogenex, University of Geneva [Switzerland], Geneva University Hospital (HUG), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Children’s Cancer Research Institute [Vienna, Austria], University of Vienna [Vienna], Cancer Center Karolinska [Karolinska Institutet] (CCK), Directors's Laboratory, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark [Lyngby] (DTU)

    المصدر: Cell
    Cell, Elsevier, 2017, 168 (1-2), pp.86-100.e15. ⟨10.1016/j.cell.2016.11.010⟩
    Cell, Vol. 168, No 1-2 (2017) pp. 86-100.e15

    مصطلحات موضوعية: 0301 basic medicine, insulin secretion, Artemisinins/administration & dosage/pharmacology, β cell, Carrier Proteins/metabolism, Diabetes Mellitus/drug therapy, Mice, Single-cell analysis, Insulin-Secreting Cells, GABA-receptor signaling, Insulin, artemisinins, gamma-Aminobutyric Acid/metabolism, Cells, Cultured, Zebrafish, gamma-Aminobutyric Acid, pancreatic endocrine transdifferentiation, ddc:617, biology, diabetes, Protein Stability, Receptors, GABA-A/metabolism, Transdifferentiation, Diabetes Mellitus, Type 1/drug therapy/pathology, 3. Good health, Cell biology, medicine.anatomical_structure, Biochemistry, ARX translocation, Artemether, MESH: Animals, Disease models, animal, Insulin/Genetics, Signal transduction, Artemisinins/Pharmacology, Single-Cell Analysis, Signal Transduction, Cell type, regenerative medicine, chemical biology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Cell Transdifferentiation/drug effects, Article, General Biochemistry, Genetics and Molecular Biology, Diabetes Mellitus, Experimental, Islets of Langerhans, 03 medical and health sciences, Genetic model, Protein Stability/drug effects, Diabetes Mellitus, medicine, Homeodomain Proteins/metabolism, Regeneration, Animals, Humans, Transcription Factors/metabolism, Transcription factor, Homeodomain Proteins, Insulin/genetics/metabolism, Gephyrin, Biochemistry, Genetics and Molecular Biology(all), Gene Expression Profiling, Pancreatic islets, Membrane Proteins, Islets of Langerhans/drug effects, Receptors, GABA-A, gephyrin, Rats, Disease Models, Animal, Diabetes Mellitus, Type 1, 030104 developmental biology, Cell Transdifferentiation, biology.protein, Membrane Proteins/metabolism, Carrier Proteins, Transcription Factors

    وصف الملف: application/pdf

  8. 8

    المؤلفون: Amato, Roberto, Miotto, Olivo, Woodrow, Charles J, Almagro-Garcia, Jacob, Sinha, Ipsita, Campino, Susana, Mead, Daniel, Drury, Eleanor, Kekre, Mihir, Sanders, Mandy, Amambua-Ngwa, Alfred, Amaratunga, Chanaki, Amenga-Etego, Lucas, Andrianaranjaka, Voahangy, Apinjoh, Tobias, Ashley, Elizabeth, Auburn, Sarah, Awandare, Gordon, Baraka, Vito, Barry, Alyssa, Boni, Maciej, Borrmann, Steffen, Bousema, Teun, Branch, Oralee, Bull, Peter, Chotivanich, Kesinee, Conway, David, Craig, Alister, Day, Nicholas, Djimde, Abdoulaye, Dolecek, Christiane, Dondorp, Arjen M, Drakeley, Chris, Duffy, Patrick, Echeverry, Diego F, Egwang, Thomas, Fairhurst, Rick, Faiz, Abul, Fanello, Caterina, Hien, Tran Tinh, Hodgson, Abraham, Imwong, Mallika, Ishengoma, Deus, Lim, Pharath, Lon, Chanthap, Marfurt, Jutta, Marsh, Kevin, Mayxay, Mayfong, Michon, Pascal, Mobegi, Victor, Mokuolu, Olugbenga, Montgomery, Jacqui, Mueller, Ivo, Kyaw, Myat Phone, Newton, Paul N, Nosten, François, Noviyanti, Rintis, Nzila, Alexis, Ocholla, Harold, Oduro, Abraham, Onyamboko, Marie, Ouédraogo, Jean-Bosco, Phyo, Aung, Plowe, Christopher, Price, Ric, Pukrittayakamee, Sasithon, Randrianarivelojosia, Milijaona, Ringwald, Pascal, Ruiz, Lastenia, Saunders, David, Shayo, Alex, Siba, Peter, Takala-Harrison, Shannon, Thanh, Thuy-Nhien, Thathy, Vandana, Verra, Federica, Wendler, Jason, White, Nicholas, Ye, Htut, Cornelius, Victoria, Giacomantonio, Rachel, Muddyman, Dawn, Henrichs, Christa, Malangone, Cinzia, Jyothi, Dushyanth, Pearson, Richard, Rayner, Julian, McVean, Gilean, Rockett, Kirk, Miles, Alistair, Vauterin, Paul, Jeffery, Ben, Manske, Magnus, Stalker, Jim, MacInnis, Bronwyn, Kwiatkowski, Dominic

    المساهمون: The Wellcome Trust Sanger Institute [Cambridge], Mahidol Oxford Tropical Medicine Research Unit, University of Oxford [Oxford]-Mahidol University [Bangkok], The Wellcome Trust Centre for Human Genetics [Oxford], University of Oxford [Oxford], Medical Research Council Unit The Gambia (MRC), National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH), National Institutes of Health [Bethesda] (NIH), Navrongo Health Research Centre [Navrongo, Ghana] (NHRC), G4 malaria group [Antananarivo, Madagascar] (IPM), Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), University of Buéa, Global and Tropical Health Division [Rocklands, Australia], Menzies School of Health Research [Australia], Charles Darwin University-Charles Darwin University, West African Centre for Cell Biology of Infectious Pathogens [Legon, Ghana] (WACCBIP), University of Ghana, National Institute for Medical Research [Tanzania] (NIMR), The Walter and Eliza Hall Institute of Medical Research (WEHI), Oxford University Clinical Research Unit [Ho Chi Minh City] (OUCRU), KEMRI-Wellcome Trust Research Programme (KWTRP), London School of Hygiene and Tropical Medicine (LSHTM), New York University School of Medicine, NYU System (NYU), Faculty of Tropical Medicine [Bangkok, Thailand], Mahidol University [Bangkok], Liverpool School of Tropical Medicine (LSTM), Faculté de Médecine, de pharmacie et d’Odonto-Stomatologie [Bamako, Mali] (FMPOS), Université de Bamako, Department of Entomology [West Lafayette], Purdue University [West Lafayette], Med Biotech Laboratories [Kampala, Ouganda] (MBL), Armed Forces Research Institute of Medical Sciences [Bangkok] (AFRIMS), Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahidol University [Bangkok]-Mahosot Hospital, Faculty of Medicine and Health Sciences [Madang, Papouasie-Nouvelle-Guinée], Divine Word University [Papouasie-Nouvelle-Guinée] (DWU), University of Ilorin, Department of Entomology [University Park], Pennsylvania State University (Penn State), Penn State System-Penn State System, University of Melbourne, Ministry of health and sport [Yangon, Myanmar] (MoHS), Eijkman Institute for Molecular Biology [Jakarta], King Fahd University of Petroleum and Minerals (KFUPM), Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM)-University of Liverpool-Wellcome Trust-University of Malawi, University of Kinshasa (UNIKIN), Institut de Recherche en Sciences de la Santé (IRSS) / Centre Muraz, Shoklo Malaria Research Unit [Mae Sot, Thailand] (SMRU), Mahidol Oxford Tropical Medicine Research Unit (MORU), Wellcome Trust-Mahidol University [Bangkok]-University of Oxford [Oxford]-Wellcome Trust-Mahidol University [Bangkok]-University of Oxford [Oxford], University of Maryland School of Medicine, University of Maryland System, Centre for Tropical Medicine and Global Health [Oxford, UK], Nuffield Department of Medicine [Oxford, UK] (Big Data Institute), University of Oxford [Oxford]-University of Oxford [Oxford], Department of Clinical Tropical Medicine [Bangkok, Thailand] (Faculty of Tropical Medicine), Global Malaria Programme, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Universidad Nacional de la Amazonía Peruana [Loreto, Perou] (UNAP), University of Dodoma [Tanzanie] (UDOM), Papua New Guinea Institute of Medical Research (PNG-IMR), Wellcome Trust-Mahidol University [Bangkok]-University of Oxford [Oxford], The sequencing, analysis, informatics and management of the Community Project are supported by the Wellcome Trust through Sanger Institute core funding (098051) and a Strategic Award (090770/Z/09/Z) and by the MRC Centre for Genomics and Global Health which is jointly funded by the Medical Research Council and the Department for International Development (DFID) (G0600718, M006212). AEB and IM acknowledge the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS., This study was conducted by the MalariaGEN Plasmodium falciparum Community Project, and was made possible by clinical parasite samples contributed by partner studies, whose investigators are represented in the author list. RA and OM contributed equally. In addition, the authors would like to thank the following individuals, who contributed to partner studies or to the MalariaGEN Resource Centre, making this study possible: James Abugri, Nicholas Amoako, Steven M Kiara, John Okombo, Rogelin Raherinjafy, Seheno Razanatsiorimalala, Hongying Jiang, Xin-zhuan Su., MalariaGEN Plasmodium Falciparum C

    المصدر: eLife, Vol 5 (2016)
    eLife
    eLife, eLife Sciences Publication, 2016, 48 (8), pp.959-964. ⟨10.7554/eLife.08714⟩
    Elife, 5, pp. 1-29
    Elife, 5, 1-29

    مصطلحات موضوعية: 0301 basic medicine, Drug resistance, Pharmacology, MESH: Asia, Southeastern/epidemiology, MESH: Malaria, Falciparum/epidemiology, Malaria, Falciparum, Artemisinin, Biology (General), GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries), Asia, Southeastern, Genetics, Molecular Epidemiology, Microbiology and Infectious Disease, education.field_of_study, MESH: Plasmodium falciparum/genetics, General Neuroscience, General Medicine, MESH: Artemisinins/pharmacology, Artemisinins, 3. Good health, Genomics and Evolutionary Biology, kelch13, Medicine, MESH: Plasmodium falciparum/drug effects, Research Article, medicine.drug, Combination therapy, plasmodium falciparum, QH301-705.5, infectious disease, MESH: Antimalarials/pharmacology, Science, 030106 microbiology, Population, malaria, MESH: Plasmodium falciparum/classification, MESH: Malaria, Falciparum/parasitology, Biology, General Biochemistry, Genetics and Molecular Biology, Antimalarials, 03 medical and health sciences, parasitic diseases, medicine, genomics, MESH: Molecular Epidemiology, education, MESH: Drug Resistance, [SDV.GEN]Life Sciences [q-bio]/Genetics, drug resistance, General Immunology and Microbiology, Molecular epidemiology, evolutionary biology, microbiology, Plasmodium falciparum, medicine.disease, biology.organism_classification, MESH: Africa/epidemiology, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], 030104 developmental biology, artemisinin, Infectious disease (medical specialty), Africa, Other, Human medicine, MESH: Plasmodium falciparum/isolation & purification, Malaria

    وصف الملف: application/pdf; pdf

  9. 9

    المساهمون: Burnet Institute [Melbourne, Victoria], Biologie et Génétique du Paludisme, Institut Pasteur [Paris] (IP), Instute of Infection, Immunity and Inflammation [Glasgow], University of Glasgow-College of Medical, Veterinary and Life Sciences [Glasgow], Wellcome Trust Centre for Molecular Parasitology-Wellcome Trust Centre for Molecular Parasitology, School of Medicine [Univ California San Diego] (UC San Diego), University of California [San Diego] (UC San Diego), University of California (UC)-University of California (UC), Karolinska Institutet [Stockholm], Columbia University Medical Center (CUMC), Columbia University [New York], African Network for Drugs and Diagnostics Innovation (ANDI), WHO-TDR Suisse-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Institut Pasteur [Paris], UC San Diego School of Medicine

    المصدر: Nature
    Nature, 2012, 484 (7395), pp.S22-S23. ⟨10.1038/484S22a⟩
    Nature, Nature Publishing Group, 2012, 484 (7395), pp.S22-S23. ⟨10.1038/484S22a⟩

    مصطلحات موضوعية: MESH: Anopheles/physiology, Plasmodium, Biomedical Research, Erythrocytes, Mosquito Control, Drug Resistance, MESH: Plasmodium/immunology, MESH: Hepatocytes/parasitology, Primaquine, MESH: Malaria/drug therapy, 0302 clinical medicine, MESH: Anopheles/parasitology, MESH: Malaria Vaccines/immunology, MESH: Antigens, Protozoan/immunology, MESH: Antimalarials/pharmacology, MESH: Animals, MESH: Drug Resistance/drug effects, MESH: Artemisinins/pharmacology, 0303 health sciences, Molecular interactions, Multidisciplinary, MESH: Plasmodium/drug effects, MESH: Malaria/immunology, MESH: Plasmodium/metabolism, MESH: Biomedical Research/organization & administration, Artemisinins, 3. Good health, Parasite biology, MESH: Sporozoites/immunology, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Sporozoites, MESH: Artemisinins/therapeutic use, Female, MESH: Malaria/epidemiology, MESH: Biomedical Research/trends, 030231 tropical medicine, Antigens, Protozoan, Computational biology, Biology, Vaccines, Attenuated, Antimalarials, 03 medical and health sciences, Medical research, Anopheles, Malaria Vaccines, Animals, Humans, MESH: Mosquito Control/methods, 030304 developmental biology, MESH: Humans, MESH: Vaccines, Attenuated/immunology, MESH: Primaquine/administration & dosage, MESH: Primaquine/metabolism, MESH: Malaria/prevention & control, MESH: Primaquine/therapeutic use, Data science, Malaria, MESH: Primaquine/adverse effects, MESH: Antimalarials/therapeutic use, MESH: Plasmodium/growth & development, Hepatocytes, MESH: Female, MESH: Erythrocytes/parasitology

  10. 10

    المساهمون: Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Chimie des Substances Naturelles (ICSN), Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)

    المصدر: Soh, P N, Witkowski, B, Olagnier, D, Nicolau, M-L, Garcia-Alvarez, M-C, Berry, A & Benoit-Vical, F 2009, ' In vitro and in vivo properties of ellagic acid in malaria treatment ' Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1100-6 . https://doi.org/10.1128/AAC.01175-08
    Antimicrobial Agents and Chemotherapy
    Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2009, 53 (3), pp.1100-6. ⟨10.1128/AAC.01175-08⟩